Inspired by challenges
MicroPhage is accelerating access to the critical information physicians need to properly treat patients with bacterial infections. By focusing our patented and proprietary Bacteriophage Amplification Technology (BAT™) on the clinical diagnostic market, we are shaping the modern approach of diagnostic testing for bacterial identification and antibiotic susceptibility/resistance testing.
The challenges we address:
- Almost all antibiotics are prescribed empirically.
- Despite best efforts, up to 62% of patients receive suboptimal or ineffective antibiotics. Why?
- Rising antibiotic resistance makes choosing appropriate antibiotics challenging
- Relevant laboratory test results are not available for 2-3 days
The MicroPhage Solution
- Accelerated bacterial identification and Antibiotic Susceptibility Tests (ID/AST) results
- Easy-to-use test kit that can be used by any hospital
Our products will provide physicians with timely information that facilitates optimization of antibiotic therapy earlier in the course of disease...In time to save lives.